Yahoo Web Search

  1. Celgene Corporation CELG too has filed a Biologics License Application (BLA) for its pipeline candidate, luspatercept, to the FDA. Meanwhile, Regeneron Pharmaceuticals, Inc...

  2. Celgene & Acceleron Submit BLA for Luspatercept to the FDA

    Zacks via Yahoo FinanceApr 08 22:11 PM

    Celgene Corporation CELG announced that it has submitted a Biologics License Application (BLA) for pipeline candidate, luspatercept, a first-in-class erythroid maturation agent ...

  3. This change lagged the S&P 500's daily loss of 0.61%. Heading into today, shares of the biotechnology company had gained 11.42% over the past month, outpacing the Medical sector's gain of 2.13% ...

  4. Celgene Corporation CELG is expected to significantly benefit from key drug Revlimid's performance in the upcoming quarterly results. The company has surpassed earnings estimates ...

  5. Celgene (CELG) Gains As Market Dips: What You Should Know

    Zacks via Yahoo FinanceApr 15 21:45 PM

    Celgene (CELG) closed the most recent trading day at $95.10, moving +1.02% from the previous trading session. This move outpaced the S&P 500's daily loss of 0.06%. Heading into today, ...

  6. On Apr 5, we issued an updated research report on Corcept Therapeutics Incorporated CORT. Corcept’s only marketed drug, Korlym, is approved for the once-daily oral treatment of hyperglycemia ...

  7. Last month, Biogen Inc (NASDAQ: BIIB) halted Phase 3 trials for aducanumab in March based on results of a futility analysis conducted by an independent data monitoring committee. While the remaining ...

  8. Concert Pharma Initiates Early-Stage Schizophrenia Study

    Zacks via Yahoo FinanceApr 11 13:46 PM

    Concert Pharmaceuticals, Inc. CNCE announced that it has initiated a multiple-ascending dose (“MAD”) phase I study on its pipeline candidate, CTP-692 (a novel deuterium-modified form of D-serine ...

  9. Bristol-Myers' Shareholders Vote for Celgene Acquisition

    Zacks via Yahoo FinanceApr 15 17:53 PM

    Bristol-Myers Squibb Company BMY announced that its shareholders have given a green signal for the impending acquisition of Celgene Corp. CELG. In January, Bristol-Myers announced that ...

  10. Celgene, Bristol Myers’ Acquisition Gets Green Signal: Celgene Corporation CELG announced that its stockholders have voted in favor of the proposed merger with Bristol-Myers ...

  1. Ads
    related to CELGENE CORPORATION